Zobrazeno 1 - 10
of 244
pro vyhledávání: '"Churchyard, Gavin"'
Autor:
Lienhardt C; French National Research Institute for Sustainable Development, Montpellier, France., Dooley KE; Division of Infectious Diseases, Vanderbilt University Medical Center, Nashville, United States of America (USA)., Nahid P; Institute for Global Health, University of California San Francisco, San Francisco, USA., Wells C; Bill & Melinda Gates Medical Research Institute, Boston, USA., Ryckman TS; Infectious Disease Division, School of Medicine, John Hopkins University, Baltimore, USA., Kendall EA; Infectious Disease Division, School of Medicine, John Hopkins University, Baltimore, USA., Davies G; Institute of Infection and Global Health, University of Liverpool, Liverpool, England., Brigden G; The Global Fund to Fight AIDS, Tuberculosis and Malaria, Geneva, Switzerland., Churchyard G; Aurum Institute, Johannesburg, South Africa., Cirillo DM; Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), San Raffaele Scientific Institute, Milan, Italy., Di Meco E; European Medicines Agency, Amsterdam, Kingdom of the Netherlands., Gopinath R; Division of Anti-Infectives, Food and Drug Administration, WashingtonDC, USA., Mitnick C; School of Medicine, Harvard Medical School, Boston, USA., Scott C; Unitaid, Geneva, Switzerland., Amanullah F; Indus Hospital, Karachi, Pakistan., Bansbach C; ChinaCat Enterprises, Gig Harbor, USA., Boeree M; University Medical Center, Radboud University, Amsterdam, Kingdom of the Netherlands., Campbell M; Clinton Health Access Initiative, Boston, USA., Conradie F; Wits Health Consortium, Johannesburg, South Africa., Crook A; MRC Clinical Trials Unit, University College of London, London, England., Daley CL; Division of Mycobacterial and Respiratory Infections, National Jewish Health, Denver, USA., Dheda K; Centre for Lung Infection and Immunity, University of Cape Town, Cape Town, South Africa., Diacon A; TASK, Cape Town, South Africa., Gebhard A; KNCV, The Hague, Kingdom of the Netherlands., Hanna D; Global Health Division, Bill & Melinda Gates Foundation, Seattle, USA., Heinrich N; Division of Infectious Diseases and Tropical Medicine, LMU University Hospital, LMU, Munich, Germany., Hesseling A; Desmond Tutu TB Centre, Stellenbosch University, Stellenbosch, South Africa., Holtzman D; Bill & Melinda Gates Medical Research Institute, Boston, USA., Jachym M; Centre Hospitalier de Bligny, Fontenay-lès-Briis, Paris, France., Kim P; French National Research Institute for Sustainable Development, Montpellier, France.; Division of Infectious Diseases, Vanderbilt University Medical Center, Nashville, United States of America (USA)., Lange C; French National Research Institute for Sustainable Development, Montpellier, France.; Institute for Global Health, University of California San Francisco, San Francisco, USA., McKenna L; French National Research Institute for Sustainable Development, Montpellier, France.; Bill & Melinda Gates Medical Research Institute, Boston, USA., Meintjes G; French National Research Institute for Sustainable Development, Montpellier, France.; Infectious Disease Division, School of Medicine, John Hopkins University, Baltimore, USA., Ndjeka N; French National Research Institute for Sustainable Development, Montpellier, France.; Institute of Infection and Global Health, University of Liverpool, Liverpool, England., Nhung NV; French National Research Institute for Sustainable Development, Montpellier, France.; The Global Fund to Fight AIDS, Tuberculosis and Malaria, Geneva, Switzerland., Nyang'wa BT; French National Research Institute for Sustainable Development, Montpellier, France.; Aurum Institute, Johannesburg, South Africa., Paton NI; French National Research Institute for Sustainable Development, Montpellier, France.; Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), San Raffaele Scientific Institute, Milan, Italy., Rao R; French National Research Institute for Sustainable Development, Montpellier, France.; European Medicines Agency, Amsterdam, Kingdom of the Netherlands., Rich M; French National Research Institute for Sustainable Development, Montpellier, France.; Division of Anti-Infectives, Food and Drug Administration, WashingtonDC, USA., Savic R; Institute for Global Health, University of California San Francisco, San Francisco, USA., Schoeman I; French National Research Institute for Sustainable Development, Montpellier, France.; School of Medicine, Harvard Medical School, Boston, USA., Makokotlela BS; French National Research Institute for Sustainable Development, Montpellier, France.; Unitaid, Geneva, Switzerland., Spigelman M; French National Research Institute for Sustainable Development, Montpellier, France.; Indus Hospital, Karachi, Pakistan., Sun E; French National Research Institute for Sustainable Development, Montpellier, France.; Indus Hospital, Karachi, Pakistan., Svensson E; University Medical Center, Radboud University, Amsterdam, Kingdom of the Netherlands., Tisile P; French National Research Institute for Sustainable Development, Montpellier, France.; School of Medicine, Harvard Medical School, Boston, USA., Varaine F; French National Research Institute for Sustainable Development, Montpellier, France.; ChinaCat Enterprises, Gig Harbor, USA., Vernon A; French National Research Institute for Sustainable Development, Montpellier, France.; University Medical Center, Radboud University, Amsterdam, Kingdom of the Netherlands., Diul MY; French National Research Institute for Sustainable Development, Montpellier, France.; Clinton Health Access Initiative, Boston, USA., Kasaeva T; French National Research Institute for Sustainable Development, Montpellier, France.; Wits Health Consortium, Johannesburg, South Africa., Zignol M; French National Research Institute for Sustainable Development, Montpellier, France.; Wits Health Consortium, Johannesburg, South Africa., Gegia M; French National Research Institute for Sustainable Development, Montpellier, France.; Wits Health Consortium, Johannesburg, South Africa., Mirzayev F; French National Research Institute for Sustainable Development, Montpellier, France.; Wits Health Consortium, Johannesburg, South Africa., Schumacher SG; French National Research Institute for Sustainable Development, Montpellier, France.; Wits Health Consortium, Johannesburg, South Africa.
Publikováno v:
Bulletin of the World Health Organization [Bull World Health Organ] 2024 Aug 01; Vol. 102 (8), pp. 600-607. Date of Electronic Publication: 2024 May 28.
Autor:
Churchyard G; The Aurum Institute, Parktown 2193, South Africa; School of Public Health, University of Witwatersrand, Johannesburg, South Africa; Department of Medicine, Vanderbilt University, Nashville, TN, USA. Electronic address: gchurchyard@auruminstitute.org., Salazar-Austin N; Department of Pediatrics, Johns Hopkins University, Baltimore, MD 21287, USA.
Publikováno v:
The Lancet. Respiratory medicine [Lancet Respir Med] 2024 Aug; Vol. 12 (8), pp. 582-583. Date of Electronic Publication: 2024 May 08.
Autor:
Matteelli A; Institute of Infectious and Tropical Diseases, WHO Collaborating Centre for Tuberculosis Prevention, University of Brescia, Brescia, Italy., Churchyard G; The Aurum Institute, Parktown, South Africa, School of Public Health, University of Witwatersrand, Johannesburg, South Africa., Cirillo D; IRCCS San Raffaele Scientific Institute, Milan, Italy., den Boon S; Global Tuberculosis Programme, World Health Organization, Geneva, Switzerland., Falzon D; Global Tuberculosis Programme, World Health Organization, Geneva, Switzerland., Hamada Y; Research Institute of Tuberculosis, Japan Anti-Tuberculosis Association, Tokyo, Japan.; University College London, London, United Kingdom., Houben RMGJ; TB Modelling Group, TB Centre, London School of Hygiene & Tropical Medicine, London, United Kingdom., Kanchar A; Global Tuberculosis Programme, World Health Organization, Geneva, Switzerland., Kritski A; Rede Brasileira de Pesquisa em Tuberculose, REDE TB, Rio de Janeiro, Brasil.; Programa Acadêmico de Tuberculose, Faculdade de Medicina, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brasil., Kumar B; The Global Coalition of TB Advocates, India., Miller C; Global Tuberculosis Programme, World Health Organization, Geneva, Switzerland., Menzies D; McGill International TB Centre, McGill University, Montreal, Quebec, Canada., Masini T; Independent consultant, Lucca, Italy.
Publikováno v:
PLOS global public health [PLOS Glob Public Health] 2024 Jul 02; Vol. 4 (7), pp. e0003306. Date of Electronic Publication: 2024 Jul 02 (Print Publication: 2024).
Autor:
Churchyard GJ; Aurum Institute NPC, Houghton, Parktown, South Africa; Department of Medicine, Vanderbilt University, Nashville, TN, USA; School of Public Health, Faculty of Health Sciences, University of Witwatersrand, Johannesburg, South Africa. Electronic address: gchurchyard@auruminstitute.org., Houben RMGJ; Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK; TB Modelling Group, TB Centre, London School of Hygiene & Tropical Medicine, London, UK., Fielding K; Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK., Fiore-Gartland AL; University of Washington, Seattle, WA, USA., Esmail H; MRC Clinical Trials Unit, University College London, London, United Kingdon; WHO Collaborating Centre for TB Research and Innovation, Institute for Global Health, University College London, London, UK., Grant AD; TB Centre, London School of Hygiene & Tropical Medicine, London, UK; Department of Clinical Research, London School of Hygiene & Tropical Medicine, London, UK; Africa Health Research Institute, KwaZulu-Natal, Durban, South Africa., Rangaka MX; MRC Clinical Trials Unit, University College London, London, United Kingdon; CIDRI-AFRICA, School of Public Health, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa., Behr M; McGill International TB Centre, McGill University, Montreal, QC, Canada., Garcia-Basteiro AL; ISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain; Centro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique; Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFECT), Barcelona, Spain., Wong EB; Africa Health Research Institute, KwaZulu-Natal, Durban, South Africa; Division of Infectious Diseases, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA., Hatherill M; South African Tuberculosis Vaccine Initiative, Department of Pathology and Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa., Mave V; Byramjee-Jeejeebhoy Government Medical College, Johns Hopkins University Clinical Research Site, Pune, India., Dagnew AF; Gates Medical Research Institute, Cambridge, MA, USA., Schmidt AC; Gates Medical Research Institute, Cambridge, MA, USA., Hanekom WA; Division of Infection and Immunity, University College London, London, United Kingdon; Africa Health Research Institute, KwaZulu-Natal, Durban, South Africa., Cobelens F; Department of Global Health and Amsterdam Institute for Global Health and Development, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, Netherlands., White RG; Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK; TB Modelling Group, TB Centre, London School of Hygiene & Tropical Medicine, London, UK.
Publikováno v:
The Lancet. Microbe [Lancet Microbe] 2024 Jul 01. Date of Electronic Publication: 2024 Jul 01.
Autor:
Tait D; Independent Consultant, Cape Town, South Africa., Diacon A; TASK Clinical Research Centre, Cape Town, South Africa., Borges ÁH; Department of Infectious Disease Immunology, Statens Serum Institut, Copenhagen, Denmark., van Brakel E; IAVI (Formerly Aeras), Cape Town, South Africa., Hokey D; Aeras, Rockville, MD, USA., Rutkowski KT; IAVI (Formerly Aeras), Cape Town, South Africa.; Aeras, Rockville, MD, USA., Hunt DJ; IAVI (Formerly Aeras), Cape Town, South Africa., Russell M; IAVI (Formerly Aeras), Cape Town, South Africa., Andersen PL; Novo Nordisk Foundation, Hellerup, Denmark.; Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark., Kromann I; Department of Vaccine Development, Statens Serum Institut, Copenhagen, Denmark., Ruhwald M; Department of Infectious Disease Immunology, Statens Serum Institut, Copenhagen, Denmark.; Foundation of Innovative New Diagnostics, Geneva, Switzerland., Churchyard G; Aurum Institute, Johannesburg, South Africa.; School of Public Health, Faculty of Health Sciences, University of Witwatersrand, Johannesburg, South Africa.; Department of Medicine, Vanderbilt University, Nashville, TN, USA., Dawson R; University of Cape Town Lung Institute, Centre for Tuberculosis Research Innovation, Cape Town, South Africa.
Publikováno v:
The Journal of infectious diseases [J Infect Dis] 2024 Apr 01. Date of Electronic Publication: 2024 Apr 01.
Autor:
Maenetje P; The Aurum Institute, Johannesburg, South Africa.; Department of Medicine, Vanderbilt University, Nashville, Tennessee, USA., Baik Y; Department of Biostatistics, Epidemiology, and Informatics, Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA., Schramm DB; Centre for HIV and STIs, National Institute for Communicable Diseases, Johannesburg, South Africa.; Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa., Vangu MDW; Department of Nuclear Medicine, Charlotte Maxeke Johannesburg Academic Hospital, University of the Witwatersrand, Johannesburg, South Africa., Wallis RS; The Aurum Institute, Johannesburg, South Africa., Mlotshwa M; The Aurum Institute, Johannesburg, South Africa., Tiemessen CT; Centre for HIV and STIs, National Institute for Communicable Diseases, Johannesburg, South Africa.; Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa., Li Y; Department of Biostatistics, Epidemiology, and Informatics, Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA., Kornfeld H; Department of Medicine, University of Massachusetts Chan Medical School, Worcester, USA., Churchyard G; The Aurum Institute, Johannesburg, South Africa.; Department of Medicine, Vanderbilt University, Nashville, Tennessee, USA.; School of Public Health, University of Witwatersrand, Johannesburg, South Africa., Auld SC; Departments of Medicine and Epidemiology, Emory University School of Medicine and Rollins School of Public Health, Atlanta, Georgia, USA., Bisson GP; Department of Biostatistics, Epidemiology, and Informatics, Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.; Department of Medicine, Division of Infectious Diseases, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Publikováno v:
The Journal of infectious diseases [J Infect Dis] 2024 Mar 14; Vol. 229 (3), pp. 824-832.
Autor:
White RG; Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, WC1E 7HT, UK. Electronic address: richard.white@lshtm.ac.uk., Fiore-Gartland AJ; Fred Hutchinson Cancer Center, Seattle, WA, USA., Hanekom WA; Africa Health Research Institute, KwaZulu Natal, South Africa., Vekemans J; International AIDS Vaccine Initiative, New York, NY, USA., Garcia-Basteiro AL; Centro de Investigação em Saúde de Manhiça, Maputo, Mozambique; ISGlobal, Hospital Clínic, Universitat de Barcelona, Barcelona, Spain; Centro de Investigación Biomédica en Red de Enfermedades Infecciosas, Barcelona, Spain., Churchyard G; Aurum Institute NPC, Parktown, South Africa., Rangaka MX; Institute for Global Health, Medical Research Council Clinical Trials Unit, University College London, London, UK; CIDRI-AFRICA, Institute of Infectious Disease and Molecular Medicine and School of Public Health, University of Cape Town, Cape Town, South Africa., Frick M; Treatment Action Group, New York, NY, USA., Behr MA; McGill International TB Centre, McGill University, Montreal, QC, Canada., Hill PC; University of Otago, Dunedin, New Zealand., Mave V; Byramjee Jeejeebhoy Government Medical College, Johns Hopkins University Clinical Research Site, Pune, Maharashtra, India; Center for Infectious Diseases in India, Johns Hopkins India, Pune, India.
Publikováno v:
The Lancet. Respiratory medicine [Lancet Respir Med] 2024 Mar; Vol. 12 (3), pp. e7-e8. Date of Electronic Publication: 2024 Jan 22.
Autor:
Hill PC; Centre for International Health, University of Otago, Dunedin, New Zealand., Cobelens F; Department of Global Health, Amsterdam University Medical Centre, Amsterdam, The Netherlands.; Amsterdam Institute for Global Health and Development, Amsterdam University Medical Centre, Amsterdam, The Netherlands., Martinez L; Department of Epidemiology, School of Public Health, Boston University, Boston, Massachusetts, USA., Garcia-Basteiro AL; Centro de Investigação em Saúde de Manhiça, Maputo, Mozambique.; Instituto de Salud Global, Hospital Clínic-Universitat de Barcelona, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Infecciosas, Barcelona, Spain., Behr MA; McGill International TB Centre, McGill University, Montreal, Quebec, Canada., Rangaka MX; Institute for Global Health, University College London, London, United Kingdom.; MRC Clinical Trials Unit, University College London, London, United Kingdom.; Centre for Infectious Diseases Research Africa, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa., Churchyard G; The Aurum Institute, Parktown, South Africa.; Department of Medicine, Vanderbilt University, Nashville, Tennessee, USA.; School of Public Health, University of the Witwatersrand, Johannesburg, South Africa., Evans T; Vaccitech, Oxford, United Kingdom., Hanekom W; Africa Health Research Institute, Durban, KwaZulu-Natal, South Africa.; Division of Infection and Immunity, University College London, London, United Kingdom., White RG; Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, United Kingdom.
Publikováno v:
The Journal of infectious diseases [J Infect Dis] 2024 Feb 14; Vol. 229 (2), pp. 616.
Autor:
Imbratta C; South African Tuberculosis Vaccine Initiative, Division of Immunology, Department of Pathology, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa., Gela A; South African Tuberculosis Vaccine Initiative, Division of Immunology, Department of Pathology, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa., Bilek N; South African Tuberculosis Vaccine Initiative, Division of Immunology, Department of Pathology, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa., Mabwe S; South African Tuberculosis Vaccine Initiative, Division of Immunology, Department of Pathology, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa., Cloete Y; South African Tuberculosis Vaccine Initiative, Division of Immunology, Department of Pathology, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa., Mortensen R; Department of Infectious Diseases Immunology, Statens Serum Institut, Copenhagen, Denmark., Borges ÁH; Department of Infectious Diseases Immunology, Statens Serum Institut, Copenhagen, Denmark., Maenetje P; Aurum Institute, Parktown, South Africa.; Department of Medicine, Vanderbilt University, Nashville, Tennessee, USA., Mlotshwa M; Aurum Institute, Parktown, South Africa.; Department of Medicine, Vanderbilt University, Nashville, Tennessee, USA., Churchyard G; Aurum Institute, Parktown, South Africa.; Department of Medicine, Vanderbilt University, Nashville, Tennessee, USA., Sudi L; Mbeya Medical Research Centre, National Institute for Medical Research (NIMR), Mbeya, Tanzania., Sabi I; Mbeya Medical Research Centre, National Institute for Medical Research (NIMR), Mbeya, Tanzania., Meewes P; BARC, South Africa., Wallis CL; BARC, South Africa.; Lancet Laboratories, Johannesburg, South Africa., Hatherill M; South African Tuberculosis Vaccine Initiative, Division of Immunology, Department of Pathology, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa., Scriba TJ; South African Tuberculosis Vaccine Initiative, Division of Immunology, Department of Pathology, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa., Nemes E; South African Tuberculosis Vaccine Initiative, Division of Immunology, Department of Pathology, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.
Publikováno v:
Cytometry. Part A : the journal of the International Society for Analytical Cytology [Cytometry A] 2023 Dec; Vol. 103 (12), pp. 992-1003. Date of Electronic Publication: 2023 Sep 28.
Autor:
Hill PC; Centre for International Health, University of Otago, Dunedin, New Zealand., Cobelens F; Department of Global Health, Amsterdam University Medical Centre, Amsterdam, The Netherlands.; Amsterdam Institute for Global Health and Development, Amsterdam University Medical Centre, Amsterdam, The Netherlands., Martinez L; Department of Epidemiology, School of Public Health, Boston University, Boston, Massachusetts, USA., Behr MA; McGill International TB Centre, McGill University, Montreal, Quebec, Canada., Churchyard G; The Aurum Institute, Parktown, South Africa.; Department of Medicine, Vanderbilt University, Nashville, Tennessee, USA.; School of Public Health, University of the Witwatersrand, Johannesburg, South Africa., Evans T; Vaccitech, Oxford, United Kingdom., Fiore-Gartland AJ; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA., Garcia-Basteiro AL; Centro de Investigação em Saúde de Manhiça, Maputo, Mozambique.; Instituto de Salud Global, Hospital Clínic-Universitat de Barcelona, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Infecciosas, Barcelona, Spain., Hanekom W; Africa Health Research Institute, KwaZulu-Natal, Durban, South Africa.; Division of Infection and Immunity, University College London, London, United Kingdom., Rangaka MX; MRC Clinical Trials Unit, University College London, London, United Kingdom.; Institute for Global Health, University College London, London, United Kingdom.; Centre for Infectious Diseases Research Africa, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa., Vekemans J; V4R, Brussels, Belgium., White RG; Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, United Kingdom.
Publikováno v:
The Journal of infectious diseases [J Infect Dis] 2023 Nov 02; Vol. 228 (9), pp. 1150-1153.